Trials / Active Not Recruiting
Active Not RecruitingNCT03613246
NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population
Clinical Outcomes of the NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population With Elevated Surgical Risk
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 346 (actual)
- Sponsor
- NVT GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study collects real-world data of patients who were treated with the ALLEGRA TAVI System TF and evaluates early and midterm clinical and quality of life outcome.
Conditions
Timeline
- Start date
- 2019-02-20
- Primary completion
- 2024-12-20
- Completion
- 2029-01-26
- First posted
- 2018-08-03
- Last updated
- 2025-11-17
Locations
14 sites across 6 countries: Finland, Germany, Italy, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03613246. Inclusion in this directory is not an endorsement.